SARS-CoV-2 Vaccine Development: An Overview and Perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 Vaccine Development: An Overview and Perspectives

Published:2020-09-18 Issue:5 Volume:3 Page:844-858
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Liu Yi¹²,Wang Kai¹,Massoud Tarik F.¹^ORCID,Paulmurugan Ramasamy¹^ORCID

Affiliation:

1. Molecular Imaging Program at Stanford (MIPS), Stanford University, 3155 Porter Drive, Palo Alto, California 94304, United States

2. Department of Critical Care Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00109

Reference139 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. Infection of dogs with SARS-CoV-2

3. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

4. A pneumonia outbreak associated with a new coronavirus of probable bat origin

5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19: from immune response to clinical intervention;Precision Clinical Medicine;2024-07-18

2. Impact assessment of virus globally: special emphasis on COVID-19, Zika, and Ebola virus;Nanostructured Drug Delivery Systems in Infectious Disease Treatment;2024

3. The WHO BioHub system: experiences from the pilot phase;BMJ Global Health;2023-08

4. Enhancement of immunogenicity and neutralizing responses against SARS-CoV-2 spike protein using the Fc fusion fragment;Life Sciences;2023-05

5. An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CLpro;Mini-Reviews in Medicinal Chemistry;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3